Transforming vaccine development

dc.creatorBlack, Steve
dc.creatorBloom, David E.
dc.creatorKaslow, David C.
dc.creatorPecetta, Simone
dc.creatorRappuoli, Rino
dc.date.accessioned2020-11-04T14:19:24Z
dc.date.accessioned2022-09-23T18:47:21Z
dc.date.available2020-11-04T14:19:24Z
dc.date.available2022-09-23T18:47:21Z
dc.date.created2020-11-04T14:19:24Z
dc.identifier1044-5323
dc.identifierhttps://doi.org/10.1016/j.smim.2020.101413
dc.identifierhttp://hdl.handle.net/20.500.12010/15299
dc.identifierhttps://doi.org/10.1016/j.smim.2020.101413
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3507428
dc.description.abstractThe urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines that are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, the smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.
dc.languageeng
dc.publisherSeminars in immunology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.subjectVaccine
dc.subjectVaccine development
dc.subjectVaccine discovery
dc.subjectSystems biology
dc.subjectMachine learning
dc.subjectPlatform technologies
dc.subjectAdjuvants
dc.subjectAdjuvants
dc.subjectSmart clinical trials
dc.subjectHuman genetics
dc.subjectRegulatory convergence
dc.subjectReal world evidence
dc.subjectVaccines safety
dc.titleTransforming vaccine development


Este ítem pertenece a la siguiente institución